赛马鲁肽
脂肪性肝炎
医学
内科学
脂肪肝
糖尿病
内分泌学
2型糖尿病
疾病
利拉鲁肽
作者
Danny Issa,Philip N. Newsome,Iris Kliers,Laura Østergaard,Michelle T. Long,Mette Skalshøi Kjær,Anna M.G. Cali,Elisabetta Bugianesi,Mary E. Rinella,Michael Roden,Vlad Ratziu
标识
DOI:10.1056/nejmoa2413258
摘要
In patients with MASH and moderate or advanced liver fibrosis, once-weekly semaglutide at a dose of 2.4 mg improved liver histologic results. (Funded by Novo Nordisk; ClinicalTrials.gov number, NCT04822181.).
科研通智能强力驱动
Strongly Powered by AbleSci AI